Variant report

Variant	nsv9451
Chromosome Location	chr16:59635240-60032841
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr16:59894857-59895035	K562	blood:	n/a	n/a
2	BACH1	chr16:59637252-59637310	H1-hESC	embryonic stem cell:	n/a	n/a
3	BCL3	chr16:59939444-59939928	A549	lung:	n/a	n/a
4	CEBPB	chr16:59732911-59733165	HepG2	liver:	n/a	n/a
5	CEBPB	chr16:59775830-59776089	A549	lung:	n/a	chr16:59775920-59775933
6	CEBPB	chr16:59919886-59920334	A549	lung:	n/a	n/a
7	CEBPB	chr16:59799271-59799430	HepG2	liver:	n/a	chr16:59799291-59799302
8	CEBPB	chr16:59937420-59937672	HepG2	liver:	n/a	chr16:59937504-59937515
9	CEBPB	chr16:59893896-59894244	Hela-S3	cervix:	n/a	chr16:59894063-59894074
10	CEBPB	chr16:59912409-59913233	Hela-S3	cervix:	n/a	n/a
11	CEBPB	chr16:59640531-59640537	A549	lung:	n/a	n/a
12	CEBPB	chr16:59782382-59782691	H1-hESC	embryonic stem cell:	n/a	n/a
13	CEBPB	chr16:59639646-59640003	A549	lung:	n/a	chr16:59639776-59639787 chr16:59639806-59639817
14	CEBPB	chr16:59893914-59894223	H1-hESC	embryonic stem cell:	n/a	chr16:59894063-59894074
15	CEBPB	chr16:59919764-59920409	A549	lung:	n/a	n/a
16	CEBPB	chr16:59912364-59913332	A549	lung:	n/a	n/a
17	CEBPB	chr16:59947442-59947768	HepG2	liver:	n/a	chr16:59947608-59947619
18	CEBPB	chr16:59933860-59934183	HepG2	liver:	n/a	chr16:59934003-59934014
19	CEBPB	chr16:59639781-59639958	K562	blood:	n/a	chr16:59639806-59639817
20	CEBPB	chr16:59900500-59900780	A549	lung:	n/a	chr16:59900637-59900648
21	CEBPB	chr16:59639640-59639961	HepG2	liver:	n/a	chr16:59639776-59639787 chr16:59639806-59639817
22	CEBPB	chr16:59652494-59652790	HepG2	liver:	n/a	chr16:59652665-59652676
23	CEBPB	chr16:59893883-59894258	HepG2	liver:	n/a	chr16:59894063-59894074
24	CEBPB	chr16:59699560-59699871	IMR90	lung:	n/a	chr16:59699727-59699740 chr16:59699728-59699739 chr16:59699729-59699738
25	CEBPB	chr16:59641136-59641336	A549	lung:	n/a	n/a
26	CEBPB	chr16:59977383-59977548	HepG2	liver:	n/a	n/a
27	CEBPB	chr16:59728926-59729209	A549	lung:	n/a	chr16:59729056-59729067
28	CEBPB	chr16:59911305-59911372	HepG2	liver:	n/a	n/a
29	CEBPB	chr16:59672961-59673060	H1-hESC	embryonic stem cell:	n/a	n/a
30	CEBPB	chr16:59984233-59984709	A549	lung:	n/a	n/a
31	CEBPB	chr16:59919936-59920268	A549	lung:	n/a	n/a
32	CEBPB	chr16:59702527-59702671	HepG2	liver:	n/a	chr16:59702597-59702608
33	CEBPB	chr16:59939572-59939923	Hela-S3	cervix:	n/a	n/a
34	CEBPB	chr16:59939568-59939835	HepG2	liver:	n/a	n/a
35	CEBPB	chr16:59639635-59639988	IMR90	lung:	n/a	chr16:59639776-59639787 chr16:59639806-59639817
36	CEBPB	chr16:59893812-59894253	IMR90	lung:	n/a	chr16:59894063-59894074
37	CEBPB	chr16:59752998-59753271	K562	blood:	n/a	chr16:59753078-59753089
38	CEBPB	chr16:59638295-59638509	HepG2	liver:	n/a	chr16:59638376-59638387 chr16:59638376-59638389 chr16:59638376-59638387 chr16:59638377-59638388
39	CEBPB	chr16:59728966-59729119	K562	blood:	n/a	chr16:59729056-59729067
40	CEBPB	chr16:59831123-59831300	HepG2	liver:	n/a	n/a
41	CEBPB	chr16:59993030-59993239	HepG2	liver:	n/a	chr16:59993119-59993130 chr16:59993121-59993132
42	CEBPB	chr16:59939128-59940087	A549	lung:	n/a	n/a
43	CEBPB	chr16:59860677-59860925	HepG2	liver:	n/a	chr16:59860797-59860808 chr16:59860799-59860810
44	CEBPB	chr16:59699603-59699905	HepG2	liver:	n/a	chr16:59699727-59699740 chr16:59699728-59699739 chr16:59699729-59699738
45	CEBPB	chr16:59652522-59652789	IMR90	lung:	n/a	chr16:59652665-59652676
46	CEBPB	chr16:59947451-59947752	A549	lung:	n/a	chr16:59947608-59947619
47	CEBPB	chr16:59752911-59753298	HepG2	liver:	n/a	chr16:59753078-59753089
48	CEBPB	chr16:59893766-59894357	A549	lung:	n/a	chr16:59894063-59894074 chr16:59893810-59893821 chr16:59893808-59893821
49	CEBPB	chr16:59638167-59638644	A549	lung:	n/a	chr16:59638376-59638387 chr16:59638376-59638389 chr16:59638185-59638197 chr16:59638376-59638387 chr16:59638377-59638388
50	CEBPB	chr16:59752926-59753295	IMR90	lung:	n/a	chr16:59753078-59753089

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr16:59790180-59790230	GM12892	blood:	n/a
2	chr16:59789071-59789121	GM12892	blood:	n/a
3	chr16:59790180-59790230	GM12892	blood:	n/a
4	chr16:59789071-59789121	GM12892	blood:	n/a
5	chr16:59789485-59789535	AG10803	skin:	n/a
6	chr16:59789030-59789080	GM12891	blood:	n/a
7	chr16:59789485-59789535	HL-60	blood:	n/a
8	chr16:59789485-59789535	GM12892	blood:	n/a
9	chr16:59788951-59789001	PFSK-1	brain:	n/a
10	chr16:59790082-59790132	IMR90	lung:	fetal
11	chr16:59790180-59790230	HRE	kidney:	n/a
12	chr16:59792836-59792886	RPTEC	kidney:	n/a
13	chr16:59789219-59789269	HCF	heart:	n/a
14	chr16:59789485-59789535	Jurkat	blood:	n/a
15	chr16:59789030-59789080	NHDF-neo	bronchial:	n/a
16	chr16:59789071-59789121	AG09319	gingival:	n/a
17	chr16:59790082-59790132	Hepatocyte	liver:	n/a
18	chr16:59790082-59790132	MCF-7	breast:	n/a
19	chr16:59789485-59789535	SAEC	small airway:	n/a
20	chr16:59790082-59790132	LNCaP	prostate:	n/a
21	chr16:59788728-59788778	NHBE	bronchial:	n/a
22	chr16:59789485-59789535	HMEC	breast:	n/a
23	chr16:59789071-59789121	HIPEpiC	eye:	n/a
24	chr16:59788951-59789001	MCF10A-Er-Src	breast:	n/a
25	chr16:59789071-59789121	ECC-1	luminal epithelium:	n/a
26	chr16:59789030-59789080	SK-N-SH_RA	brain:	n/a
27	chr16:59789071-59789121	BE2_C	brain:	n/a
28	chr16:60010823-60010873	Hepatocyte	liver:	n/a
29	chr16:59788728-59788778	PFSK-1	brain:	n/a
30	chr16:59789485-59789535	AG09309	skin:	n/a
31	chr16:59788728-59788778	K562	blood:	n/a
32	chr16:59656293-59656343	AoSMC	blood vessel:	n/a
33	chr16:59786279-59786329	AG09309	skin:	n/a
34	chr16:59789071-59789121	HCM	heart:	n/a
35	chr16:59786279-59786329	RPTEC	kidney:	n/a
36	chr16:59786279-59786329	SK-N-SH	brain:	n/a
37	chr16:59790082-59790132	GM12878	blood:	n/a
38	chr16:60010823-60010873	HepG2	liver:	n/a
39	chr16:59656293-59656343	SAEC	small airway:	n/a
40	chr16:59656293-59656343	U87	brain:	n/a
41	chr16:60010823-60010873	RPTEC	kidney:	n/a
42	chr16:59789030-59789080	AoSMC	blood vessel:	n/a
43	chr16:59790180-59790230	GM06990	blood:	n/a
44	chr16:59786279-59786329	HEEpiC	esophagus:	n/a
45	chr16:59789219-59789269	AG04450	lung:	fetal
46	chr16:59656293-59656343	GM12891	blood:	n/a
47	chr16:59788951-59789001	LNCaP	prostate:	n/a
48	chr16:59789219-59789269	HRCEpiC	kidney:	n/a
49	chr16:59656293-59656343	HCT-116	colon:	n/a
50	chr16:59789030-59789080	SKMC	muscle:	n/a

No.	Distal block	Cell Line	Cell type
1	chr16:59973167..59974731-chr16:60006878..60009430,2	MCF-7	breast:
2	chr16:59635524..59637585-chr16:59638803..59640976,2	K562	blood:
3	chr16:59962673..59964307-chr16:59966390..59968142,2	K562	blood:
4	chr16:59635524..59637585-chr16:59638803..59640976,2	K562	blood:
5	chr16:59944781..59947331-chr16:59948422..59950704,2	MCF-7	breast:
6	chr16:59710678..59713121-chr16:59778438..59780009,2	K562	blood:
7	chr16:59802014..59804199-chr16:59814012..59816551,2	K562	blood:
8	chr16:59710678..59713121-chr16:59778438..59780009,2	K562	blood:
9	chr16:59962673..59964307-chr16:59966390..59968142,2	K562	blood:
10	chr16:60023642..60024389-chr17:54895894..54896686,2	MCF-7	breast:
11	chr16:59772981..59773721-chrX:108093803..108094584,2	HCT-116	colon:
12	chr16:59730238..59732939-chr3:97563003..97565712,2	MCF-7	breast:
13	chr16:60004466..60006529-chr5:21480625..21483296,2	MCF-7	breast:
14	chr16:59909180..59912142-chr16:59912804..59915333,2	K562	blood:
15	chr16:59802014..59804199-chr16:59814012..59816551,2	K562	blood:
16	chr16:59909180..59912142-chr16:59912804..59915333,2	K562	blood:
17	chr16:59944781..59947331-chr16:59948422..59950704,2	MCF-7	breast:
18	chr16:59973167..59974731-chr16:60006878..60009430,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RP11-105C20.2.1-5	chr16:59788689-59788752	NONHSAT142892
2	lnc-SETD6-13	chr16:59690034-59690240	NONHSAT142891
3	lnc-RP11-105C20.2.1-5	chr16:59788365-59788930	NONHSAT142894
4	lnc-RP11-105C20.2.1-5	chr16:59785865-59785999	NONHSAT142892
5	lnc-RP11-105C20.2.1-5	chr16:59744120-59744199	NONHSAT142892
6	lnc-SETD6-13	chr16:59689506-59689824	NONHSAT142891
7	lnc-SETD6-2	chr16:59889257-59889429	ENSG00000261807.1
8	lnc-RP11-105C20.2.1-5	chr16:59788045-59789095	NONHSAT142893
9	lnc-RP11-105C20.2.1-5	chr16:59743897-59744027	NONHSAT142892

Variant related genes	Relation type
ENSG00000260240	TF binding region
APOOP5	TF binding region
ENSG00000261807	TF binding region
ENSG00000270222	TF binding region
ENSG00000260240	CpG island
APOOP5	CpG island
ENSG00000261807	CpG island
ENSG00000270222	CpG island

Extended variants
information (count: 8500 )
Associated
traits (count: 76 )

Variant overlapped rSNPs/rCNVs (count:8500 , 50 per page) page: 1 2 3 4 5 6 7 ... 170

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs550157217	chr16:59635315-59635316	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs571707563	chr16:59635347-59635348	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs538792725	chr16:59635417-59635418	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs539526535	chr16:59635459-59635460	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs572130337	chr16:59635478-59635479	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs184317258	chr16:59635530-59635531	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs554451985	chr16:59635538-59635539	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs576108167	chr16:59635619-59635620	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs562808499	chr16:59635661-59635662	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs146906698	chr16:59635671-59635672	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs564972148	chr16:59635675-59635676	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs576854103	chr16:59635689-59635690	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs541153405	chr16:59635697-59635698	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs189044134	chr16:59635715-59635716	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs568574857	chr16:59635742-59635743	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs141413134	chr16:59635855-59635856	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs533359252	chr16:59635931-59635932	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs545242720	chr16:59635932-59635933	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs561625247	chr16:59635947-59635948	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs560303938	chr16:59635984-59635985	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs531953711	chr16:59636001-59636002	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs150831330	chr16:59636066-59636067	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs571777271	chr16:59636073-59636074	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs138202722	chr16:59636158-59636159	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs113103516	chr16:59636175-59636176	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs527819022	chr16:59636176-59636177	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs553934329	chr16:59636177-59636178	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs565696748	chr16:59636189-59636190	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs181130255	chr16:59636195-59636196	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs184596968	chr16:59636216-59636217	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs554588996	chr16:59636330-59636331	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs112008155	chr16:59636338-59636339	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs180693856	chr16:59636350-59636351	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs558694036	chr16:59636375-59636376	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs112915090	chr16:59636396-59636397	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs145990783	chr16:59636456-59636457	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs115448849	chr16:59636474-59636475	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs186129082	chr16:59636486-59636487	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs541838019	chr16:59636527-59636528	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs563173870	chr16:59636585-59636586	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs191012738	chr16:59636639-59636640	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs543782278	chr16:59636663-59636664	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs368412268	chr16:59636712-59636713	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs565442130	chr16:59636742-59636743	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs532577425	chr16:59636783-59636784	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs547438547	chr16:59636818-59636819	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs565831962	chr16:59636866-59636867	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs530173153	chr16:59636868-59636869	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs567671287	chr16:59636869-59636870	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs375780892	chr16:59636893-59636894	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:76)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Wilms tumour	21544195	CNVD
Lung cancer	18438408	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16702952	CNVD
Medulloblastoma	16968546	CNVD
Prostate cancer	19242612	CNVD
Cancer	22429812	CNVD
Ewing''s sarcoma	21437220	CNVD
Ewing''s sarcoma	22429812	CNVD
Melanoma	18172304	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Multiple myeloma	21628407	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Breast cancer	21364760	CNVD
Ewing''s sarcoma	17952124	CNVD
Bladder cancer	21909424	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Infertility	21528002	CNVD
Breast cancer	21806811	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	17603634	CNVD
Prostate cancer	16573809	CNVD
small cell lung cancer	20016488	CNVD
Myelofibrosis	22110671	CNVD
Cancer	21183584	CNVD
Ovarian cancer	20844748	CNVD
Neurodevelopmental disorder	22521361	CNVD
Glioblastoma multiforme	22286061	CNVD
Autism	18414403	CNVD
Breast cancer	20409316	CNVD
Chordoma	18071362	CNVD
Prostate cancer	17245344	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Ovarian cancer	21720365	CNVD
Leiomyosarcoma	16982739	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Autism	20972252	CNVD
Invasive breast cancer	20972252	CNVD
Breast cancer	17142309	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Autism	20531469	CNVD

Chromatin state (count:657 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:59625600-59639400	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
2	chr16:59631400-59637200	Weak transcription	NHLF	lung
3	chr16:59631800-59637200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
4	chr16:59631800-59638400	Weak transcription	HSMM	muscle
5	chr16:59634000-59636400	Weak transcription	Brain Anterior Caudate	brain
6	chr16:59634800-59636600	Enhancers	Brain Cingulate Gyrus	brain
7	chr16:59634800-59637600	Enhancers	Brain Hippocampus Middle	brain
8	chr16:59635000-59635400	Enhancers	Brain Inferior Temporal Lobe	brain
9	chr16:59635000-59635600	Enhancers	Breast Myoepithelial Primary Cells	Breast
10	chr16:59635000-59637400	Enhancers	Brain Substantia Nigra	brain
11	chr16:59635200-59635600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
12	chr16:59635200-59635600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
13	chr16:59635200-59635600	Enhancers	NHDF-Ad	bronchial
14	chr16:59635200-59635800	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
15	chr16:59635200-59640200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
16	chr16:59635400-59636400	Weak transcription	Brain Inferior Temporal Lobe	brain
17	chr16:59635600-59638200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
18	chr16:59635600-59639800	Weak transcription	NHDF-Ad	bronchial
19	chr16:59636400-59636600	Enhancers	Brain Anterior Caudate	brain
20	chr16:59636400-59637200	Enhancers	Brain Inferior Temporal Lobe	brain
21	chr16:59636600-59637000	Weak transcription	Brain Anterior Caudate	brain
22	chr16:59637000-59637400	Enhancers	Brain Anterior Caudate	brain
23	chr16:59637200-59637400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
24	chr16:59637200-59637400	Enhancers	NHLF	lung
25	chr16:59637200-59637800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
26	chr16:59637400-59637800	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
27	chr16:59637800-59639600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
28	chr16:59637800-59645600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
29	chr16:59638200-59639000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
30	chr16:59638400-59638600	Enhancers	HSMM	muscle
31	chr16:59639000-59639400	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
32	chr16:59639400-59639800	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
33	chr16:59639400-59640000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
34	chr16:59639600-59640000	Enhancers	Pancreatic Islets	Pancreatic Islet
35	chr16:59639800-59640000	Enhancers	NHDF-Ad	bronchial
36	chr16:59640200-59645000	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
37	chr16:59643400-59643600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
38	chr16:59644200-59644600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
39	chr16:59644600-59650600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
40	chr16:59645000-59645200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
41	chr16:59645000-59645600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
42	chr16:59645000-59646000	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
43	chr16:59645000-59646000	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
44	chr16:59645000-59646000	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
45	chr16:59645200-59645600	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
46	chr16:59645200-59645800	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
47	chr16:59645400-59646000	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
48	chr16:59645400-59646000	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
49	chr16:59645600-59648400	Enhancers	HUES64 Cell Line	embryonic stem cell
50	chr16:59645600-59650200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links